China Medical System Holdings_Providing professional financial news and data related to China Medical System Holdings, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

China Medical System Holdings(00867.HK): Self-Developed Complement Factor B Inhibitor CMS-D017 Approved for Clinical Trials in AMD Indication

Tags：

China Medical System Holdings 00867.HK

2026-07-15

Finance
Ubox Online (02429.HK): Full Circulation of H Shares Approved by HKEX
Finance
Chengdu Expressway (01785.HK): Signs Precast Concrete Component Procurement Contract for Chengdu-Wenjiang-Qionglai Expressway Expansion Project Worth Approximately RMB 234 Million
Finance
Prinx Chengshan (01809.HK): CEO Reshuffle – Che Baozhen Steps Down, Jiang Xizhou Appointed as President
Finance
Fameglow Holdings(03774.HK): Enters Technology Development Agreement with Sunseeker to Jointly Develop AI Anti-Aging Platform
Finance
Zhongtai Futures (01461.HK): Positive Profit Alert, Interim Net Profit Attributable to Parent Expected to Rise 190% to 210%
Finance
InnoCare Pharma Limited(09969.HK): Phase III Registrational Trial of Soficitinib (ICP-332) for Moderate-to-Severe Atopic Dermatitis Meets Primary Endpoint Successfully
Finance
Cinda International Holdings (00111.HK): Profit Forecast, Interim Consolidated Net Profit Expected at HK$32 Million to HK$38 Million
Finance
Beijing Enterprises Holdings (00392.HK): Proposed Issuance of Sci-Tech Innovation Corporate Bonds Capped at RMB 1 Billion
Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (July 15, 2026)
Finance
Haixi Pharmaceuticals (02637.HK): Non-executive Director Wang Xinkun Resigns; Chen Tingze Nominated as Candidate for Executive Director

Scan QR Code

Download App